A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT04540796 · COMPLETED

Trial details

NCT number: NCT04540796
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2020-11-20
Primary completion: 2025-09-09
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.